Merck & Co Inc (MRK) stock price$146.46 · 379.86 ₾
One Merck & Co Inc share costs 146.46 dollars, or 379.86 lari at the National Bank rate. Price as of 10.11.2026 22:03; the market is open.
In short
10 November 2026- One Merck & Co Inc (MRK) share costs $146.46, or 379.86 ₾. Day change: −1.55%.
- The price is at 86% of its 52-week range ($84.35 - $156.92).
- 25 of 35 analysts rate it a buy, average rating 3.9/5.
- Over the last 12 months the stock moved +71.05%.
- Next earnings report: 02.02.2027.
This is an automatic summary of prices, not investment advice.
Price in dollars
$146.46
Price in lari
379.86 ₾
Today's change
−1.55%
Dividend yield
2.87%
10.11.2026 22:03 · Market open · 1 $ = 2.5936 ₾ · National Bank · Methodology
Price history
…
Key figures
- 52-week range
- $84.35 - $156.92
- 52-week change
- +71.05%
- Market cap
- $366.7B
- P/E (trailing 12 months)
- 147.6
- Earnings per share (EPS)
- $0.98
- Beta (volatility vs market)
- 0.13
- Exchange
- NYSE
- Industry
- Pharmaceuticals
- Next earnings report
- 02.02.2027, after the close
Figures: Finnhub, updated 10.11.2026
Dividend
- Dividend yield
- 2.87%
- Annual dividend per share
- $3.27 (8.48 ₾)
- Payout ratio
- 51.3%
- Dividend growth, 5-year average
- 5.9%
Yield = annual dividend / share price. Dividends are not guaranteed and can change. They are taxed: US companies withhold tax on dividends paid to non-residents.
Value of MRK shares
| Shares | Lari | Dollars |
|---|---|---|
| 1 MRK | 379.86 ₾ | $146.46 |
| 5 MRK | 1,899.29 ₾ | $732.30 |
| 10 MRK | 3,798.59 ₾ | $1,464.60 |
| 25 MRK | 9,496.47 ₾ | $3,661.50 |
| 50 MRK | 18,992.93 ₾ | $7,323.00 |
| 100 MRK | 37,985.87 ₾ | $14,646.00 |
At the current price, without broker fees or the exchange-rate spread.
Recent closing prices
| Date | Price, $ | Price, ₾ |
|---|---|---|
| 10.11.2026 | 146.46 | 379.96 |
| 09.11.2026 | 148.39 | 385.06 |
| 06.11.2026 | 146.51 | 380.27 |
| 05.11.2026 | 147.07 | 381.76 |
| 04.11.2026 | 149.93 | 389.37 |
| 03.11.2026 | 144.67 | 375.75 |
| 02.11.2026 | 148.36 | 385.62 |
| 30.10.2026 | 149.52 | 388.14 |
| 29.10.2026 | 146.33 | 379.83 |
| 28.10.2026 | 140.93 | 365.85 |
| 27.10.2026 | 141.82 | 368.25 |
Analyst ratings: MRK
Buy3.9 / 5
35 analysts, November 2026
- Strong buy8
- Buy17
- Hold10
- Sell0
- Strong sell0
How the view is changing
- November 2026
- October 2026
- September 2026
- August 2026
Earnings per share: estimate and actual
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Q3 2026 | $2.10 | $2.49 | +18.46% beat |
| Q2 2026 | $-0.27 | $-0.13 | +52.33% beat |
| Q1 2026 | $-1.52 | $-1.28 | +16.00% beat |
| Q4 2025 | $2.03 | $2.09 | +2.98% beat |
This is the combined recommendation of analysts at US investment banks and brokers (source: Finnhub, updated monthly). It is not advice from GFX.GE.
How to buy Merck & Co Inc (MRK) stock from Georgia
- 1Open an account with a licensed broker: a Georgian bank's brokerage or an international broker. Check who regulates it.
- 2Deposit money and convert it to dollars. Compare the broker's rate with the rates on GFX.GE: the gap adds straight to your cost.
- 3Search for the ticker MRK and place an order: at the market price (market) or at a price you set (limit).
Full guide: costs, documents, tax
Are you a broker or an investing app?Your offer can go here: this page is read by people who are about to buy a stock.Contact usAbout the company
Merck & Co. is a US drugmaker (MSD outside North America). Its main product is the cancer drug Keytruda, plus vaccines (Gardasil) and animal health. It pays a quarterly dividend.
Website: merck.com
FAQ: MRK
How much is one Merck & Co Inc (MRK) share in lari?
At the top of this page: MRK's dollar price times the National Bank USD/GEL rate. Your real cost at a broker depends on fees and its exchange rate.
What is P/E?
P/E is the share price divided by the last 12 months' earnings per share. A high P/E means investors expect growth or the share is expensive. On its own it isn't enough to judge a stock.
Prices and figures are for information and come from Finnhub; ETF facts from issuers' pages. Lari values at the National Bank rate. This is not investment advice or a recommendation to buy or sell.